+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Swine Healthcare Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 167 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6162459
The global swine healthcare market size is further expected to grow in the forecast period of 2025-2034 at a CAGR of 7.90%.

Growing Research and Development Activities to Increase Diagnostic Efficiencies to Augment the Global Swine Healthcare Industry

Diagnostic tests are crucial for swine diseases for early detection and subsequent start of the treatment procedures. The surge in the cases of swine fever and swine influenza, and associated deaths has led to the enhancement of swine disease diagnostic facilities in hospitals and clinics. Over the forecast period, the technological advancements in diagnostic procedures in laboratories to increase the understanding of swine disease investigation algorithm are likely to bolster the segment’s growth.

Moreover, the anticipated increase in the incorporation of diagnostic imaging in veterinary hospitals is likely to generate demand for accessories and diagnostic equipment in the coming years, supporting the overall swine healthcare market. The increasing research and development activities in laboratory diagnostics, particularly for African swine fever to facilitate quick and efficient diagnostics to enhance the recovery process from the potential fatality are further propelling the segment’s growth.

North America Leads with a Substantial Share in the Market for Swine Healthcare

The market in the North America region is being driven by the policies of the governments which are favouring the research and development activities in therapeutic and pharmaceutical laboratories committed towards the development of swine disease treatment medications. The United States is one of the highest spenders on healthcare which is a major driving factor of the market.

In addition to this, the United States has the largest pork eating population. This factor is further escalating concerns pertaining to swine healthcare. Furthermore, the thriving commercial pork production in the region owing to the increasing exports and rising domestic demand is likely to provide impetus to the market in the coming years.

Market Segmentation

Swine healthcare is defined as an umbrella term which includes healthcare products, diagnostic kits, and treatment procedures, aimed towards bolstering comfort during various types of swine diseases. Swine disease can happen to both humans and pigs and require efficient treatment in order to prevent fatalities. The swine healthcare market has been divided based on product, diseases, and distribution channels, among others.

Based on product, the market can be segmented into:

  • Diagnostic Tests (Further breakup by diagnostic test types)
  • Enzyme Linked Immuno-Sorbent Assay (ELISA)
  • Rapid Immuno Migration (RIM)
  • Agar Gel Immuno-Diffusion (AGID)
  • Polymerase Chain Reaction (PCR)
  • Diagnostic Imaging
  • Others
  • Therapeutics (Further breakup by therapeutics type)
  • Vaccines
  • Parasiticides
  • Anti-Infectives
  • Feed Additives
  • Others

By disease, the swine healthcare market has been divided into:

  • Exudative Dermatitis
  • Porcine Parvovirus
  • Coccidiosis
  • Swine Dysentery
  • Respiratory Diseases
  • Others

On the basis of route of administration, the market has been categorised into:

  • Injectable
  • Oral

The major distribution channels based on which the market has been segmented are as follows:

  • Veterinary Hospitals
  • Retail Pharmacy
  • Online

Regional markets for the product include:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Increasing Prevalence of Swine Diseases to Boost the Growth of the Swine Healthcare Industry

The global swine healthcare market is being driven by the increasing prevalence of respiratory diseases and swine dysentery. This is propelling the demand for swine healthcare products from hospitals and clinics in order to bolster the diagnostic and treatment process for timely recovery. Meanwhile, the robust promotion of government initiatives and schemes encouraging the development of vaccines to prevent swine flu and swine fever is further propelling the market growth.

The anticipated increase in the research and development activities aimed towards the bringing innovative oral treatments to the market, owing to the increasing inclination towards minimally invasive treatment procedures, is likely to add to the market growth. The rising pork and beacon eating population is anticipated to propel the demand for healthy swine livestock in the forecast period which is likely to pose great impact on the swine healthcare market in the future.

Key Players in the Global Market for Swine Healthcare

The report gives a detailed analysis of the following key players in the global market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
  • Boehringer Ingelheim International GmbH
  • Phibro Animal Health Corporation
  • Merck & Co., Inc.,
  • Ceva Animal Health, LLC
  • IDEXX Laboratories, Inc
  • Virbac Corporation
  • Others
The comprehensive report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Table of Contents

1 Executive Summary
1.1 Market Size 2024-2025
1.2 Market Growth 2025(F)-2034(F)
1.3 Key Demand Drivers
1.4 Key Players and Competitive Structure
1.5 Industry Best Practices
1.6 Recent Trends and Developments
1.7 Industry Outlook
2 Market Overview and Stakeholder Insights
2.1 Market Trends
2.2 Key Verticals
2.3 Key Regions
2.4 Supplier Power
2.5 Buyer Power
2.6 Key Market Opportunities and Risks
2.7 Key Initiatives by Stakeholders
3 Economic Summary
3.1 GDP Outlook
3.2 GDP Per Capita Growth
3.3 Inflation Trends
3.4 Democracy Index
3.5 Gross Public Debt Ratios
3.6 Balance of Payment (BoP) Position
3.7 Population Outlook
3.8 Urbanisation Trends
4 Country Risk Profiles
4.1 Country Risk
4.2 Business Climate
5 Global Swine Healthcare Market Analysis
5.1 Key Industry Highlights
5.2 Global Swine Healthcare Historical Market (2018-2024)
5.3 Global Swine Healthcare Market Forecast (2025-2034)
5.4 Global Swine Healthcare Market by Product
5.4.1 Diagnostic Tests
5.4.1.1 Market Share
5.4.1.2 Historical Trend (2018-2024)
5.4.1.3 Forecast Trend (2025-2034)
5.4.1.4 Breakup by Diagnostic Tests Type
5.4.1.4.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
5.4.1.4.2 Rapid Immuno Migration (RIM)
5.4.1.4.3 Agar Gel Immuno-Diffusion (AGID)
5.4.1.4.4 Polymerase Chain Reaction (PCR)
5.4.1.4.5 Diagnostic Imaging
5.4.1.4.6 Others
5.4.2 Therapeutics
5.4.2.1 Market Share
5.4.2.2 Historical Trend (2018-2024)
5.4.2.3 Forecast Trend (2025-2034)
5.4.2.4 Breakup by Therapeutics Type
5.4.2.4.1 Vaccines
5.4.2.4.2 Parasiticides
5.4.2.4.3 Anti-Infectives
5.4.2.4.4 Feed Additives
5.4.2.4.5 Others
5.5 Global Swine Healthcare Market by Diseases
5.5.1 Exudative Dermatitis
5.5.1.1 Market Share
5.5.1.2 Historical Trend (2018-2024)
5.5.1.3 Forecast Trend (2025-2034)
5.5.2 Coccidiosis
5.5.2.1 Market Share
5.5.2.2 Historical Trend (2018-2024)
5.5.2.3 Forecast Trend (2025-2034)
5.5.3 Respiratory Diseases
5.5.3.1 Market Share
5.5.3.2 Historical Trend (2018-2024)
5.5.3.3 Forecast Trend (2025-2034)
5.5.4 Swine Dysentery
5.5.4.1 Market Share
5.5.4.2 Historical Trend (2018-2024)
5.5.4.3 Forecast Trend (2025-2034)
5.5.5 Porcine Parvovirus
5.5.5.1 Market Share
5.5.5.2 Historical Trend (2018-2024)
5.5.5.3 Forecast Trend (2025-2034)
5.5.6 Others
5.6 Global Swine Healthcare Market by Route of Administration
5.6.1 Injectable
5.6.1.1 Market Share
5.6.1.2 Historical Trend (2018-2024)
5.6.1.3 Forecast Trend (2025-2034)
5.6.2 Oral
5.6.2.1 Market Share
5.6.2.2 Historical Trend (2018-2024)
5.6.2.3 Forecast Trend (2025-2034)
5.7 Global Swine Healthcare Market by Distribution Channel
5.7.1 Veterinary Hospitals
5.7.1.1 Market Share
5.7.1.2 Historical Trend (2018-2024)
5.7.1.3 Forecast Trend (2025-2034)
5.7.2 Retail Pharmacy
5.7.2.1 Market Share
5.7.2.2 Historical Trend (2018-2024)
5.7.2.3 Forecast Trend (2025-2034)
5.7.3 Online
5.7.3.1 Market Share
5.7.3.2 Historical Trend (2018-2024)
5.7.3.3 Forecast Trend (2025-2034)
5.8 Global Swine Healthcare Market by Region
5.8.1 Market Share
5.8.1.1 North America
5.8.1.2 Europe
5.8.1.3 Asia Pacific
5.8.1.4 Latin America
5.8.1.5 Middle East and Africa
6 Regional Analysis
6.1 North America
6.1.1 Historical Trend (2018-2024)
6.1.2 Forecast Trend (2025-2034)
6.1.3 Breakup by Country
6.1.3.1 United States of America
6.1.3.2 Canada
6.2 Europe
6.2.1 Historical Trend (2018-2024)
6.2.2 Forecast Trend (2025-2034)
6.2.3 Breakup by Country
6.2.3.1 United Kingdom
6.2.3.2 Germany
6.2.3.3 France
6.2.3.4 Italy
6.2.3.5 Others
6.3 Asia Pacific
6.3.1 Historical Trend (2018-2024)
6.3.2 Forecast Trend (2025-2034)
6.3.3 Breakup by Country
6.3.3.1 China
6.3.3.2 Japan
6.3.3.3 India
6.3.3.4 ASEAN
6.3.3.5 Australia
6.3.3.6 Others
6.4 Latin America
6.4.1 Historical Trend (2018-2024)
6.4.2 Forecast Trend (2025-2034)
6.4.3 Breakup by Country
6.4.3.1 Brazil
6.4.3.2 Argentina
6.4.3.3 Mexico
6.4.3.4 Others
6.5 Middle East and Africa
6.5.1 Historical Trend (2018-2024)
6.5.2 Forecast Trend (2025-2034)
6.5.3 Breakup by Country
6.5.3.1 Saudi Arabia
6.5.3.2 United Arab Emirates
6.5.3.3 Nigeria
6.5.3.4 South Africa
6.5.3.5 Others
7 Market Dynamics
7.1 SWOT Analysis
7.1.1 Strengths
7.1.2 Weaknesses
7.1.3 Opportunities
7.1.4 Threats
7.2 Porter’s Five Forces Analysis
7.2.1 Supplier’s Power
7.2.2 Buyer’s Power
7.2.3 Threat of New Entrants
7.2.4 Degree of Rivalry
7.2.5 Threat of Substitutes
7.3 Key Indicators for Demand
7.4 Key Indicators for Price
8 Competitive Landscape
8.1 Supplier Selection
8.2 Key Global Players
8.3 Key Regional Players
8.4 Key Player Strategies
8.5 Company Profiles
8.5.1 Boehringer Ingelheim International GmbH
8.5.1.1 Company Overview
8.5.1.2 Product Portfolio
8.5.1.3 Demographic Reach and Achievements
8.5.1.4 Certifications
8.5.2 Phibro Animal Health Corporation
8.5.2.1 Company Overview
8.5.2.2 Product Portfolio
8.5.2.3 Demographic Reach and Achievements
8.5.2.4 Certifications
8.5.3 Merck & Co., Inc.,
8.5.3.1 Company Overview
8.5.3.2 Product Portfolio
8.5.3.3 Demographic Reach and Achievements
8.5.3.4 Certifications
8.5.4 Ceva Animal Health, LLC
8.5.4.1 Company Overview
8.5.4.2 Product Portfolio
8.5.4.3 Demographic Reach and Achievements
8.5.4.4 Certifications
8.5.5 IDEXX Laboratories, Inc
8.5.5.1 Company Overview
8.5.5.2 Product Portfolio
8.5.5.3 Demographic Reach and Achievements
8.5.5.4 Certifications
8.5.6 Virbac Corporation
8.5.6.1 Company Overview
8.5.6.2 Product Portfolio
8.5.6.3 Demographic Reach and Achievements
8.5.6.4 Certifications
8.5.7 Others

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Phibro Animal Health Corporation
  • Merck & Co., Inc.,
  • Ceva Animal Health, LLC
  • IDEXX Laboratories, Inc
  • Virbac Corporation

Table Information